Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of January 4th – 10th, 2021.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view the full article.
Jay Z Made it Clear He Will Be Playing a Big Role With the Newly Formed Issuer and Why He Got Involved
Subversive Capital Acquisition Corp. (OTCQX: SBVCF) held a conference call where the company’s newly appointed Chief Visionary Officer Shawn “Jay-Z” Carter made an appearance. During the investor call, he stated “The idea was to create a brand, a house of brands and create opportunity for those that were negatively impacted by this prohibitionary era. And all the disproportionate laws and the ways the laws were set up to affect black and brown people.”
Psychedelics Are Quickly Going Mainstream and With FDA Support, Several Clinical Studies, and Easing Restrictions on Psilocybin, the Story Could Gain Even More Momentum in 2021
Better, big pharmaceutical companies could begin to enter the Psychedelics space. With the story gaining big momentum, some of the top companies to keep an eye on include: NeonMind Biosciences (CSE: NEON), Havn Life Sciences (CSE: HAVN), Field Trip Health (OTC: FTRPF), Numinus Wellness (OTC: LKYSD), and Cybin Inc. (NEO: CYBN).
A Double Dose of Good News This Past Week Sparked a Rapid Response From the Marijuana Industry, With Multi-State Operators Moving to Ramp Up Their Businesses, and Fast
On the morning of Jan. 6, when the results of Georgia’s Senate race were turning in favor of Democrats and New York Governor Andrew Cuomo proposed to legalize marijuana in his state, Curaleaf (OTCQX: CURLF) executives suddenly realized the …